KPIs & Operating Metrics(New)
Breakdown Of AssetsContractual ObligationCost Of RevenueCustomer Additions AnnualCustomers Count AnnualDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitIncome (Loss) Before Income Taxes By RegionLong Lived AssetsNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNo. Of Genes ShippedNo. Of Genes Shipped AnnualNo. Of Orders TotalNo. Of Orders Total AnnualNo. Of ShipmentsOpex As A % Of Total Revenue %OPEX SegregationOrder BreakdownProperty And Equipment, Net BreakdownRevenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By IndustryRevenue By Industry %Revenue By Industry AnnualRevenue By Industry Annual %Revenue By ProductRevenue By Product %Revenue By Product AnnualRevenue By Product Annual %Revenue Mix From Repeat Customers %Shipped ProductsValue Of Orders
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Cost Of Revenue: 2018-2025

Historic Cost of Revenue for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $48.2 million.

  • Twist Bioscience's Cost of Revenue rose 3.65% to $48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $185.6 million, marking a year-over-year increase of 3.31%. This contributed to the annual value of $185.6 million for FY2025, which is 3.31% up from last year.
  • As of Q3 2025, Twist Bioscience's Cost of Revenue stood at $48.2 million, which was up 7.62% from $44.8 million recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's Cost of Revenue registered a high of $48.2 million during Q3 2025, and its lowest value of $19.0 million during Q1 2021.
  • For the 3-year period, Twist Bioscience's Cost of Revenue averaged around $44.6 million, with its median value being $44.8 million (2025).
  • Per our database at Business Quant, Twist Bioscience's Cost of Revenue skyrocketed by 56.16% in 2022 and then declined by 3.10% in 2025.
  • Over the past 5 years, Twist Bioscience's Cost of Revenue (Quarterly) stood at $27.1 million in 2021, then rose by 8.82% to $29.4 million in 2022, then surged by 44.47% to $42.5 million in 2023, then increased by 7.85% to $45.9 million in 2024, then climbed by 3.65% to $48.2 million in 2025.
  • Its Cost of Revenue was $48.2 million in Q3 2025, compared to $44.8 million in Q2 2025 and $46.8 million in Q1 2025.